Food News and Research

RSS

FDA approves Lannett's NDA for Morphine Sulfate Oral Solution

Lannett Company, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved the company's 505(b)(2) New Drug Application (NDA) for Morphine Sulfate Oral Solution on June 23, 2011.

24 Jun 2011

Disordered eating behaviors carried into young adulthood and beyond

Adolescents who diet and develop disordered eating behaviors (unhealthy and extreme weight control behaviors and binge eating) carry these unhealthy practices into young adulthood and beyond, according to a study conducted by University of Minnesota researchers and published in the July 2011 issue of the Journal of the American Dietetic Association.

24 Jun 2011

Bodies resist weight loss efforts when food intake is reduced drastically

If you've been trying to lose weight and suspect your body's working against you, you may be right, according to a University of Illinois study published in Obesity.

24 Jun 2011

'Predatory' marketing pattern geared to lure young African Americans into becoming smokers

Tobacco companies increased the advertising and lowered the sale price of menthol cigarettes in stores near California high schools with larger populations of African-American students, according to a new study from the Stanford School of Medicine.

24 Jun 2011

G20 agriculture ministers reach deal aimed at addressing high food prices

"G20 farm ministers settled a deal on Thursday to tackle high food prices, agreeing to a watered-down declaration that fell short of France's ambitious proposals to tighten regulation of commodity markets," Reuters reports.

24 Jun 2011

Pfizer and Pain Therapeutics receive FDA Complete Response Letter for resubmission of REMOXY NDA

Pfizer and Pain Therapeutics, Inc. announced that a Complete Response Letter was received from the U.S. Food and Drug Administration (FDA) on the resubmission to the new drug application (NDA) for REMOXY® (oxycodone) Extended-Release Capsules CII. Pfizer is working to evaluate the issues described in the Complete Response Letter and plans to have further discussions with FDA around them.

24 Jun 2011

Maize-derived collagen has proline hydroxylation levels similar to human collagen

Synthetic collagen has a wide range of applications in reconstructive and cosmetic surgery and in the food industry. For proper function in animals a certain number of prolines within the protein need to be hydroxylated. BioMed Central's open access journal BMC Biotechnology reports that for the first time the α1 chain of type 1 collagen has been produced in maize with similar levels of proline hydroxylation to human collagen.

24 Jun 2011

Hedging tool for farmers needs safeguards

Writing in the Center for Global Development's "Views From The Center" blog about the creation of a hedging tool by the World Bank and J.P. Morgan to help protect farmers from volatile food prices in developing countries, CGD Vice President for Corporate Affairs Todd Moss says that having safeguards in place to "prevent speculation or abuse" and "credible private sector partners will be essential" to the program's success.

24 Jun 2011

Small 'antifreeze' molecules more effective in protecting proteins than larger ones

Scientists have made an important step forward in their understanding of cryoprotectants - compounds that act as natural 'antifreeze' to protect drugs, food and tissues stored at sub-zero temperatures.

24 Jun 2011

Hormone ghrelin mediates stress-induced food-reward behavior

Many people when stressed turn to high calorie "comfort foods". Despite the contribution this behavior makes to the current obesity epidemic, little is known about the molecules and nervous system circuits that control it. Insight into this could provide new targets for the development of therapeutics to curb this potentially detrimental behavior.

24 Jun 2011

GTRI develops novel iPhone application for patients with Parkinson's

Researchers at the Georgia Tech Research Institute (GTRI) have developed a novel iPhone application that may enable persons with Parkinson's disease and certain other neurological conditions to use the ubiquitous devices to collect data on hand and arm tremors and relay the results to medical personnel.

24 Jun 2011

Endo's complete response for new formulation of OPANA ER NDA accepted by the FDA

Endo Pharmaceuticals announced today that it received notification from the U.S. Food and Drug Administration (FDA) that Endo's complete response to the FDA's Jan. 7, 2011 Action Letter relating to Endo's new drug application (NDA) for a new formulation of OPANA ER has been accepted.

24 Jun 2011

$Inhaled corticosteroids linked to increased risk of fractures in patients with COPD$

Inhaled corticosteroids linked to increased risk of fractures in patients with COPD

Patients with chronic obstructive pulmonary disease (COPD) who use inhaled corticosteroids to improve breathing for more than six months have a 27 percent increased risk of bone fractures, new Johns Hopkins-led research suggests.

24 Jun 2011

Lithium can prevent aggregation of toxic proteins and cell loss linked with Parkinson's

Lithium profoundly prevents the aggregation of toxic proteins and cell loss associated with Parkinson's disease (PD) in a mouse model of the condition.

24 Jun 2011

Mylan introduces generic Entocort EC capsules for treatment of Crohn's disease

Mylan Inc. today announced that the U.S. District Court for the District of Delaware has found after trial that Mylan subsidiary Mylan Pharmaceuticals Inc. does not infringe the asserted claims of U.S. Patent No. 5,643,602 with its Abbreviated New Drug Application for Budesonide Capsules, 3 mg, the generic version of AstraZeneca's Entocort EC capsules, a treatment for Crohn's disease.

24 Jun 2011

USPTO issues Notice of Allowance for Neurocrine's NBI-98854 to treat tardive dyskinesia

Neurocrine Biosciences, Inc. announced today that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for the Company's proprietary Vesicular Monoamine Transporter 2 inhibitor, NBI-98854.

24 Jun 2011

Hunger hormone likely to cause stress-linked complex eating behaviors

We are one step closer to deciphering why some stressed people indulge in chocolate, mashed potatoes, ice cream and other high-calorie, high-fat comfort foods. UT Southwestern Medical Center-led findings, in a mouse study, suggest that ghrelin - the so-called "hunger hormone" - is involved in triggering this reaction to high stress situations.

24 Jun 2011

Australian chefs and food bloggers support Oxfam’s 2011 Stop Hunger Appeal with a special cookbook

Acclaimed Australian chefs and food bloggers have donated recipes to a special edition Oxfam cookbook to encourage Australians to get behind the international aid agency’s new ‘Stop Hunger’ appeal.

24 Jun 2011

Adeona enters agreement to begin proprietary zinc-based therapy Phase IIb trial in ALS

Adeona Pharmaceuticals, Inc., a developer of innovative medicines for serious central nervous system diseases, announced today that it has expanded its pipeline of proprietary zinc-based therapies to include a planned Phase IIb clinical trial of patients suffering from amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's Disease.

24 Jun 2011

New report offers policy recommendations to combat early childhood obesity

A new national report offers policy recommendations to curb the high rates of obesity among America's youngest children.

24 Jun 2011

Food News and Research

FDA approves Lannett's NDA for Morphine Sulfate Oral Solution

Disordered eating behaviors carried into young adulthood and beyond

Bodies resist weight loss efforts when food intake is reduced drastically

'Predatory' marketing pattern geared to lure young African Americans into becoming smokers

G20 agriculture ministers reach deal aimed at addressing high food prices

Pfizer and Pain Therapeutics receive FDA Complete Response Letter for resubmission of REMOXY NDA

Maize-derived collagen has proline hydroxylation levels similar to human collagen

Hedging tool for farmers needs safeguards

Small 'antifreeze' molecules more effective in protecting proteins than larger ones

Hormone ghrelin mediates stress-induced food-reward behavior

GTRI develops novel iPhone application for patients with Parkinson's

Endo's complete response for new formulation of OPANA ER NDA accepted by the FDA

Inhaled corticosteroids linked to increased risk of fractures in patients with COPD

Lithium can prevent aggregation of toxic proteins and cell loss linked with Parkinson's

Mylan introduces generic Entocort EC capsules for treatment of Crohn's disease

USPTO issues Notice of Allowance for Neurocrine's NBI-98854 to treat tardive dyskinesia

Hunger hormone likely to cause stress-linked complex eating behaviors

Australian chefs and food bloggers support Oxfam’s 2011 Stop Hunger Appeal with a special cookbook

Adeona enters agreement to begin proprietary zinc-based therapy Phase IIb trial in ALS

New report offers policy recommendations to combat early childhood obesity

The future is bioengineered: Synthetic biology and global sustainability eBook

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Latest News